Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BetaTec, a specialized division of the BarthHaas Group, is a biotechnology company focused on the extraction and application of bioactive compounds from hops for non-brewing industries. The company is a global leader in providing natural antimicrobial solutions, utilizing hop acids like beta acids to control bacterial growth in sugar processing, ethanol production, and animal nutrition. Beyond industrial applications, BetaTec is actively involved in life sciences research, exploring the therapeutic potential of hop-derived phytochemicals for human health, particularly in the areas of anti-inflammation and metabolic regulation. Their product portfolio, including established brands like BetaStab and IsoStab, offers sustainable and natural alternatives to traditional antibiotics and synthetic processing aids.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BetaTec.